SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

Home・Akcijų sąrašas・Sartorius Stedim Biotech.

Sartorius Stedim Biotech.

Uždarymo kaina

SektoriusFinansų sektorius

171 -0.47

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

170.5

Max

174.3

Pagrindiniai rodikliai
By Trading Economics
Pajamos	41M 88M
Pardavimai	-11M 762M
P/E Sektoriaus vid.	57.428 58.236
Pelnas, tenkantis vienai akcijai	1.17
Pelno marža	11.569
Darbuotojai	10,456
EBITDA	26M 225M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+36.9% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-07-23

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-2.7B 15B
Ankstesnė atidarymo kaina	171.47
Ankstesnė uždarymo kaina	171

Naujienos nuotaikos

By Acuity

92%

3 / 438 reitingas Finance

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

202.7 / 211.7 Palaikymas ir pasipriešinimas

Sartorius Stedim Biotech. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-05-22 16:33; UTC

Uždarbis

Pagrindinės rinkos jėgos

Webull Shares Slide on 1Q Loss, Soaring Costs

2026-05-22 21:10; UTC

Uždarbis

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

2026-05-22 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-05-22 20:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-05-22 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-05-22 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-05-22 19:47; UTC

Uždarbis

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

2026-05-22 19:17; UTC

Rinkos pokalbiai

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

2026-05-22 19:10; UTC

Rinkos pokalbiai

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

2026-05-22 18:54; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-05-22 18:54; UTC

Rinkos pokalbiai

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

2026-05-22 18:38; UTC

Rinkos pokalbiai

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

2026-05-22 18:35; UTC

Įsigijimai, susijungimai, perėmimai

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

2026-05-22 18:09; UTC

Rinkos pokalbiai

Centralized Crypto Lending Slows in 1Q -- Market Talk

2026-05-22 17:58; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

2026-05-22 17:54; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2026-05-22 17:54; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-05-22 17:54; UTC

Rinkos pokalbiai

Canada Minister May Be Distancing From Online-Streaming Order -- Market Talk

2026-05-22 17:03; UTC

Rinkos pokalbiai

Canada Spending Obligations on Streamers Is More Severe Beneath Surface -- Market Talk

2026-05-22 16:54; UTC

Rinkos pokalbiai

Crypto Spot Volumes Fall 14% in April -- Market Talk

2026-05-22 16:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-05-22 16:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-05-22 16:20; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2026-05-22 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-05-22 16:16; UTC

Rinkos pokalbiai

TSX Growth Driven Almost Entirely by Materials Sector -- Market Talk

2026-05-22 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-05-22 15:55; UTC

Rinkos pokalbiai

Trump Admin Grants Reinforce IBM's Quantum Computing Leadership -- Market Talk

2026-05-22 15:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-05-22 15:42; UTC

Rinkos pokalbiai

Oil Continues as Leading Indicator for All Markets -- Market Talk

2026-05-22 15:35; UTC

Rinkos pokalbiai

Gas Prices May Limit Spread of Inflationary Pressures in Canada -- Market Talk

Akcijų palyginimas

Kainos pokytis

Sartorius Stedim Biotech. Prognozė

Kainos tikslas

By TipRanks

36.9% į viršų

12 mėnesių prognozė

Vidutinis 233 EUR 36.9%

Aukščiausias 262 EUR

Žemiausias 210 EUR

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Sartorius Stedim Biotech. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių Sartorius Stedim Biotech. akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

202.7 / 211.7Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Rinkos nuotaikos

By Acuity

3 / 438 reitingas Finansų sektorius

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.